Chinese medical device company Zylox-Tonbridge Medical Technology Co Ltd (HKG:2190) announced on Monday that its ZYLOX Unicorn Vascular Closure Device (VCD) has received regulatory approval in Indonesia.

This is the first international market clearance for ZYLOX Unicorn Vascular Closure Device and the company's first market authorisation in Southeast Asia.

The device offers an extended closure range from 5F to 22F and is compatible with large-bore access sites, enabling broader clinical applications and reaching previously unmet needs in vascular intervention.

ZYLOX Unicorn VCD was granted marketing authorisation in China in June 2024.